Accumen
Accumen partners with hospitals and health systems to deliver laboratory excellence and comprehensive patient blood management services. Founded in 2011 and acquired by hc1 in 2025, its capabilities now integrate into hc1's AI-powered hc1 IQ lab intelligence platform serving 450+ health systems.
- Company typePrivate
- Founded2011
- HeadquartersSan Diego, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Accumen does
Accumen is a healthcare services and technology company headquartered in San Diego, California that partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management. Founded in 2011, the company historically provided consulting, operational improvement, and analytics services targeting clinical laboratory performance and transfusion medicine, supported by tuck-in acquisitions of Chi Solutions (2016), Halfpenny Technologies (2019), and 3DR Labs (2019).
Following its acquisition by hc1 in January 2025, Accumen's capabilities have been integrated into the hc1 IQ™ agentic intelligence platform, which unifies clinical intelligence, operational analytics, supply chain optimization, and market growth into a single AI-powered ecosystem. The platform comprises four modules — Clinical IQ™, Ops IQ™, Source IQ™, and Signal IQ™ — that process 12B+ lab results, 277M claims records, 89M patient profiles, and 600K clinical histories. Underlying capabilities include predictive analytics, autonomous agents, anomaly detection, supply and workflow optimization, and generative AI (Voice AI and Gen AI for dictation and workflows). Disclosed customer outcomes include $500K–$2M in test utilization savings per health system annually, 10–15% supply cost reductions, 20%+ operational efficiency improvements, and 10–20% outreach revenue growth.
The business model is enterprise SaaS and services-based, targeting large health systems and reference laboratories. The combined entity cites 450+ hospitals and health systems as customers, impacting 25M+ patient lives, with named customers including Sonora Quest Laboratories, Bon Secours Mercy Health, Quest Diagnostics, Rush University Medical Center, UNC Health, and Norman Regional. Specific pricing is not publicly disclosed. Following the January 2025 acquisition, Accumen operates as a subsidiary within hc1's broader healthcare AI strategy; the $6.25M funding round backing the deal was led by Health Cloud Capital and A1 Health Ventures.
Accumen firmographics
Firmographics- Name
- Accumen
- Legal name
- Accumen
- Website
- https://accumen.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- Accumen partners with hospitals and health systems to deliver laboratory excellence and comprehensive patient blood management services. Founded in 2011 and acquired by hc1 in 2025, its capabilities now integrate into hc1's AI-powered hc1 IQ lab intelligence platform serving 450+ health systems.
- Ownership category
- akta.pro rank
Accumen industry classification
Industry- Product category
- Healthcare Diagnostics Analytics Software
- NAICS
- Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Lab Analytics, Utilization Management & Operational Intelligence (HLACAMAK)
- akta.pro secondary industry
- Enterprise Integration Engines & Interface Management (HL7 v2/X12/API) (HLACABAC)
Keywords
Where Accumen is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
Accumen business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales
Accumen product offering
Product offeringCore offering
Accumen partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management. Following its acquisition by hc1, Accumen's operations now reside within the hc1 IQ™ agentic intelligence platform, an AI-powered ecosystem that unifies clinical intelligence, operational analytics, supply chain optimization, and market growth solutions to transform lab data into strategic advantage for health systems.
Product overview
Accumen, now part of hc1 following acquisition, operates the hc1 IQ™ platform — a unified agentic intelligence platform that transforms lab data into strategic advantage. The platform consists of four integrated modules: Clinical IQ™ for clinical intelligence and care gap closure, Ops IQ™ for operational analytics and workflow optimization, Source IQ™ for supply chain optimization and contract management, and Signal IQ™ for market intelligence and revenue growth. These modules share a unified data layer processing 12B+ lab results, 277M claims records, and 89M patient profiles, enabling healthcare organizations to close care gaps, cut costs, and drive growth across their operations.
Differentiator
Problem solved
Functional benefit
Products and services
- hc1 IQ™ The agentic intelligence platform that unifies clinical intelligence, operational analytics, supply chain optimization, and market growth into a single AI-powered ecosystem. Transforms lab data into strategic advantage for health systems by closing care gaps, cutting costs, and driving growth.
- Clinical IQ™ Clinical intelligence module that applies clinician-built AI to identify at-risk patients, reduce unnecessary testing, and ensure the right test reaches the right patient at the right time. Reduces unnecessary test orders by 15-30% and identifies undiagnosed chronic conditions early.
- Ops IQ™ Operational analytics module delivering real-time visibility into turnaround times, staffing efficiency, and workflow bottlenecks. AI predicts problems before they impact patient care, improving turnaround time by 20%+ and maximizing analyzer utilization.
- Source IQ™ Supply chain optimization module combining market intelligence, utilization analytics, and AI-powered forecasting. Achieves average 10-15% reduction in supply costs through vendor-agnostic contract optimization and predictive inventory management.
- Signal IQ™ Market growth and data intelligence module analyzing market signals, referral patterns, and client behavior. Helps identify high-value acquisition targets, predict and prevent client attrition, and increase outreach revenue 10-20%.
Companies that use Accumen
Customer profileIdeal customer profiles1 record
Accumen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Accumen partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- hc1corehc1 completed a $6.25 million funding round following its acquisition of Accumen. Accumen was acquired by hc1 and its technology/operations are now integrated into hc1's AI-powered lab intelligence platform.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
Accumen competitors and assessment
Company assessmentDirect peers
- CliniSys: CliniSys delivers laboratory information systems used by hospital and reference labs across multiple geographies. Its end-to-end LIS and lab informatics focus makes it a comparable direct competitor in the lab intelligence space.
- Sunquest Information Systems: Sunquest provides laboratory information systems (LIS) and diagnostic informatics used by hospitals and reference labs. It directly competes with hc1 IQ's lab intelligence, LIS connectivity, and operational analytics positioning.
- LabVantage Solutions: LabVantage provides laboratory information management systems (LIMS) used in clinical and analytical labs. It competes with hc1 IQ in lab informatics, workflow optimization, and operational analytics for hospital and reference laboratories.
- Xifin: Xifin offers cloud-based laboratory analytics, revenue cycle management, and outreach solutions for clinical labs and hospitals. It overlaps directly with hc1 IQ's Signal IQ and Source IQ modules serving health system labs.
Emerging players
- LeanDNA: LeanDNA applies analytics and AI to supply chain and operational optimization in lab-adjacent and healthcare environments. It partially overlaps with hc1 IQ's Source IQ and Ops IQ modules for cost reduction and workflow optimization.
Broad incumbents
- Siemens Healthineers: Siemens Healthineers provides Atellica laboratory diagnostics and analytics used in hospital and reference labs. It competes with hc1 IQ by combining analyzer instrumentation, middleware, and operational intelligence in a vertically integrated offering.
- Bio-Rad Laboratories: Bio-Rad provides clinical diagnostics and laboratory quality management products used by hospital and reference labs. While primarily an instrumentation and controls vendor, its lab quality and data offerings create partial overlap with hc1 IQ's operational and quality analytics.
- Oracle Health (Cerner): Oracle Health's Cerner Millennium includes laboratory and pathology solutions used across large health systems. Its installed base and enterprise IT bundling position it as a broad incumbent alternative to standalone lab intelligence platforms like hc1 IQ.
- Roche Diagnostics: Roche Diagnostics delivers laboratory analyzers, lab informatics, and clinical decision support through its diagnostics division. It overlaps with hc1 IQ in lab data analytics and clinical intelligence for health systems.
- Epic Systems (Beaker): Epic's Beaker LIS module provides laboratory and pathology functionality within its dominant EHR platform. As the leading hospital EHR, Epic competes with hc1 IQ by embedding lab analytics and LIS connectivity into its broader enterprise suite.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Accumen social profiles
Digital presenceAccumen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Accumen leadership team
Management profileNumber of profiles
Profiles3 records
Accumen funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Accumen M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Accumen
What does Accumen do?
Accumen partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management. Following its acquisition by hc1, Accumen's operations now reside within the hc1 IQ™ agentic intelligence platform, an AI-powered ecosystem that unifies clinical intelligence, operational analytics, supply chain optimization, and market growth solutions to transform lab data into strategic advantage for health systems.
Is Accumen a public or private company?
Accumen is a private company. It is classified as corporate owned and is currently acquired.
When was Accumen founded?
Accumen was founded in 2011. It employs 101 to 250 people.
Where is Accumen based?
Accumen is headquartered in San Diego, United States, in the North America region.
Who are Accumen's main competitors?
Direct peers on record are CliniSys, Sunquest Information Systems, LabVantage Solutions and Xifin. LeanDNA is listed as an emerging player. Broad incumbents are Siemens Healthineers, Bio-Rad Laboratories, Oracle Health (Cerner), Roche Diagnostics and Epic Systems (Beaker).
Does Accumen have an API?
No public API is recorded for Accumen.
What industry is Accumen in?
Accumen's product category is Healthcare Diagnostics Analytics Software. Its primary akta.pro industry code is HLACAMAK, Lab Analytics, Utilization Management & Operational Intelligence, with a secondary code of HLACABAC, Enterprise Integration Engines & Interface Management (HL7 v2/X12/API). Its NAICS code is 6215 and its SIC code is 8071.